DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Feasibility study of a proton irradiation facility for fadiobiological measurements at an 18 MeV Cyclotron
A feasibility study of an experimental setup for the irradiation of biological samples at
the cyclotron facility installed at the National Centre of Accelerators (Seville, Spain) is presented.
This cyclotron, which counts on an external beam line for interdisciplinary research purposes,
produces an 18 MeV proton beam, which is suitable for the irradiation of mono-layer cultures for the
measurement of proton cell damages and Relative Biological Effectiveness (RBE) at energies below the
beam nominal value. Measurements of this kind are of interest for proton therapy, since the variation
of proton RBE at the distal edge of the Bragg curve may have implications in clinical proton therapy
treatments. In the following, the characteristics of the beam line and the solutions implemented for
the irradiation of biological samples are described. When dealing with the irradiation of cell cultures,
low beam intensities and broad homogeneous irradiation fields are required, in order to assure
that all the cells receive the same dose with a suitable dose rate. At the cyclotron, these constraints
have been achieved by completely defocusing the beam, intercepting the beam path with tungsten
scattering foils and varying the exit-window-to-sample distance. The properties of the proton beam
thus obtained have been analysed and compared with Monte Carlo simulations. The results of this
comparison, as well as the experimental measurement of the lateral dose profiles expected at the
position of samples are presented. Meaningful dose rates of about 2–3 Gy/min have been obtained.
Homogeneous lateral dose profiles, with maximum deviations of 5%, have been measured at a
distance of approximately 50 cm in air from the exit window, placing a tungsten scattering foil of
200 µm in the beam path., This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Grant No. 675265, OMA—Optimization of Medical Accelerators, from the Spanish Ministry of Economy and Competitiveness under Grant No. FPA2016-77689-C2-1-R, and from the Council for Innovation, Science and Commerce of the Andalusian Government under Grant No. P12-FQM-1605., Peer reviewed